Association between winter season and desmopressin treatment efficiency in children with monosymptomatic nocturnal enuresis: a pilot study [PDF]
International Brazilian Journal of Urology, 2022 Objectives: The purpose of our study was to assess the association between the winter season and desmopressin treatment failure in South Chinese children with monosymptomatic nocturnal enuresis (MNE).
Mengkui Sun +4 more
doaj +3 more sources
Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
Research and Practice in Thrombosis and Haemostasis, 2022 Background Desmopressin is an important treatment option in nonsevere hemophilia A because it has several benefits compared with factor (F) concentrates, including no inhibitor risk and much lower costs.
Anne‐Fleur Zwagemaker +17 more
doaj +2 more sources
Is Desmopressin Useful in the Evaluation of Cushing Syndrome? [PDF]
Journal of Clinical Endocrinology and Metabolism, 2022 The desmopressin test was first described 30 years ago. Based on the differential secretagogue properties of desmopressin on ACTH release between normal and corticotroph tumor cells, this test was intended to facilitate the diagnosis of Cushing's ...
Frédéric Castinetti, André Lacroix
openalex +2 more sources
A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial [PDF]
International Brazilian Journal of Urology, 2020 Introduction: Nocturnal enuresis (enuresis) is one of the most common developmental problems of childhood, which has often a familial basis, causes mental and psychological damage to the child and disrupts family solace.
Parvin Mousavi Ghanavati +2 more
doaj +2 more sources
Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease [PDF]
Endocrine Connections, 2017 Recurrence of Cushing’s disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence.
Alberto Giacinto Ambrogio +4 more
doaj +2 more sources
Desmopressin in moderate hemophilia A patients: a treatment worth considering
Haematologica, 2018 Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed.
Janneke I. Loomans +12 more
doaj +2 more sources
Current Urology, 2022 . Objectives:. This study aimed to investigate the effect of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of children with primary monosymptomatic nocturnal enuresis (MNE) with desmopressin melt versus an enuresis alarm.
Umut Unal +5 more
doaj +2 more sources
Desmopressin and the risk of hyponatremia: A population-based cohort study.
PLoS Medicine, 2019 BACKGROUND:Desmopressin was approved by the Food and Drug Administration (FDA) in 1978 for use in diabetes insipidus and bleeding disorders, but it is also prescribed off-label for patients with nocturia.
Michael Fralick +4 more
doaj +2 more sources
Desmopressin and bleeding risk after percutaneous kidney biopsy
BMC Nephrology, 2019 Background Desmopressin is used to reduce bleeding after kidney biopsy but evidence supporting its use is weak, especially in patients with elevated creatinine.
Ambarish Athavale +3 more
doaj +2 more sources
Effect of desmopressin on bleeding outcomes after native renal biopsy: a systematic review and meta-analysis [PDF]
Scientific ReportsPercutaneous kidney biopsy is a key diagnostic tool in nephrology but carries a risk of post-procedure bleeding, with complications ranging from minor hematomas to life-threatening hemorrhages.
Ammar Yasser Ali +8 more
doaj +2 more sources